TA you are really good at projecting things that better exemplify yourself.
Anyways, the proof of a short and distort conspiracy going on for 9 years here is irrefutable; sort of like the proof that Zimmer Biomet was/is a strategic partner. Like Joe, whether you are directly or indirectly involved with this short and distort scheme, you help aid the conspiracy with your constant bashing; market manipulation through stock bashing on social media. However unlike Joe, almost everything you post is false..outside of pointing to the stockprice being driven lower...without admitting that this short and distort campaign is the reason for that.
Example of method these funds us to illegally work together to naked short offerings and cover using shares from another fund as well as showcasing an example of it happening here. Plus a brief explanation how these funds work together to walk the stockprice lower. https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174696175
This post shows this conspiracy of funds go after companies with promising/valuable assets, the potential value of Sintx IP, and the various methods used by the CEO to protect Sintx IP from this conspiracy of funds: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174697529
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies